Brief Hx: liver tumor, elevated afp 
This study has been compared to the previous study at 2018.08.15 
CT of Liver without and with IV enhancement triphasic scans studies   
Techniques:  
From lower chest to liver inferior edge in 5-mm contiguous section, contrast medium injected, arterial phase scan starting at 30 sec after initiation of injection; portal phase scan performed in 20 sec after the end of the arterial phase; and venous phase scan at 20 sec after the end of the portal phase  
Findings: 
Calcified pulm. nodules ¡q5mm may be due to chronic granulomas) over bil. lower lungs 
One lung nodule about 0.9cm in LLL r/o metastatic lesion 
Relative low density of liver is compatible with fatty liver  
Large early enhanced liver nodule about 7cm in S7-8 with early washout, another smaller nodules in S7 about 1.3cm and S8 about 1.4cm also with early enhancement and early washout, favoring HCCs 
One hypodense liver nodule about 2.0cm in S4 with fatty component but increase of size, nature? r/o harmatoma 
Patency of the portal veins but focal A-P shunting over S8 liver 
Mild splenomegaly 
No ascites 
No definite biliary dilatation, but gallstones are noted 
Unremarkable change of the pancreas 
No abnormal fluid collection in the abdomen  
No hydronephrosis 
No evident enlarged retroperitoneal LNs 
IMP: 
Multiple tiny chronic granulomas in bil. LL but suspect one metastatic nodule in LLL 
Multiple gallstones 
At least three early enhanced HCCs in S7 & S8 (1.3, 1.4 & 7.0cm) 
One S4 hypodense complex nodule in S4, nature? 
 
(tentatuive tumor staging) 
¡´Imaging Report Form for Hepatocellua Carcinoma (AJCC 8th Edition) 
1.Tumor Number/Location:  
Number: ¡³1 ¡³2 ¡´3 Multiple: 
Location: ¡¼  
2.Tumor Size:  
    ¡³Measurable: 7 cm (the largest tumor) 
    ¡³Non-measurable 
3.Tumor Characteristics and Associated Liver Features 
    ¡³Vascular invasion  
    ¡³Extrahepatic spread  
    ¡³Ascites  
    ¡³Portal vein thrombosis, location  
    ¡³Portosystemic collateral vessel 
    ¡³Typical enhancement pattern (hypervascular enhancement and early wash-out) 
3.Pathology: ¡³Not available ¡³Available (Pathology type:¡¼) 
 
-------------------Primary Tumor(T)-------------------------- 
 Tx  ¡³ Primary tumor cannot be assessed  
 T0  ¡³ No primary tumor  
Stage I 
T1   ¡³ Solitary tumor ¡Ø2 cm, or ¡r 2cm without vascular invasion 
T1a  Solitary tumor ¡Ø2 cm 
T1b  Solitary tumor ¡r 2cm without vascular invasion 
Stage II 
T2   ¡³ Solitary tumor ¡r2cm with vascular invasion, or multiple tumors,none ¡r5cm  
Stage III 
T3   ¡´Multiple tumors more than 5 cm  
T4   ¡³TSingle tumor or multiple tumors of any size involving a major 
branch of the portal vein or hepatic vein, or tumor(s) with direct 
invasion of adjacent organs other than the gallbladder or with 
perforation of visceral peritoneum  
-------------------Regional Lymph Nodes(N)----------------- 
Nx   ¡³Regional lymph nodes cannot be assessed  
N0   ¡´No regional lymph nodes 
Stage IVA 
N1   ¡³Regional lymph node metastasis  
     ¡³Periceliac, ¡³Hilar( common bile duct, hepatic artery, portal vein and cystic duct) ¡³Peripancreatic ¡³Paraaortic ¡³Portocaval ¡³Retrocaval 
¡³Others_______  
-------------------Distant Metastasis(M)---------------------- 
Stage IVB 
M1  ¡³Distant metastasis 
¡³ Invasion of gallbladder 
¡³ Cardiophrenic, Mesenteric, Retrocrural LN 
Imaging stage   T3 N0( in this study) 